The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Hosted on MSN
AARD stock crashes 34% – here’s why this analyst finds it ‘hard to lean into’ Aardvark at this stage
・BTIG downgraded Aardvark Therapeutics to ‘Neutral’ from ‘Buy’ but did not provide a price target, according to The Fly. ・The firm said it is hard to bet on Aardvark given the uncertainties and the ...
Capital Global Life Sciences Fund IV, L.P. Decheng, a 10% owner of $AARD, bought 625,000 shares of the company on 02-14-2025 for an estimated $10,000,000. This trade ...
Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission. Major institutions are defined as firms or individuals that exercise ...
SAN FRANCISCO, May 19, 2026 /PRNewswire/ -- On March 2, 2026, investors in Aardvark Therapeutics (NASDAQ: AARD) saw the price of their shares crater $7.02 (-56%) after the company announced that it ...
SAN FRANCISCO, April 28, 2026 (GLOBE NEWSWIRE) -- On March 2, 2026, investors in Aardvark Therapeutics (NASDAQ: AARD) saw the price of their shares crater $7.02 (-56%) after the company announced that ...
Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results